Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.Biologics, an oncology management company, has announced that a new oral drug for the treatment of relapsed small cell lung cancer, Hycamtin capsules, is now available through its oncology pharmacy.
Subscribe to our email newsletter
Doctors who specialize in treating cancer choose to have Biologics dispense prescriptions for their patients because of its fast turn around times, exceptional service and clinical oncology expertise, the company said.
Robin Smith, CEO and founder of Biologics, said: “Biologics is proud to provide these services to the oncology community. People with cancer who have the advantage of taking a pill instead of intravenous therapy require expert clinical oncology support between visits with their oncologists to enhance compliance, mitigate side effects and improve clinical outcomes.”